Sun Pharma Advanced Research Company Ltd.

•

sparc.lifeBSE: 532872NSE: SPARC

Market Cap₹ 6,391 Cr.

Current Price

High / Low₹ 289 / 108

Stock P/E4.0

Book Value₹ 41

Price to Book2.78

Dividend Yield0.00 %

ROCE163.9 %

ROE276.9 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has a good return on equity (ROE) track record: 3 Years ROE 51.9%
Operating margins have improved to 85.1% from -85.1%
Company comfortably covers its interest (46.5x coverage)
Company maintains a comfortable, low leverage position
Company converts assets efficiently - asset turnover of 1.5x

CONS

Operating cash flow has been negative in recent years
Company has a low return on capital employed of -86.8%
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -1.25x)
Free cash flow has been persistently negative
Total debt has risen sharply - up 115.4% year on year
Working capital days have increased from -1770 to 215 days

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareBusiness ServicesBusiness Support

Part ofNIFTY MICROCAP250 NIFTY TOTAL MKT

S.No.	Name
1.	PFOCUS	312.75	210.73	24356.15	0.00	-457.78	-514.43	12668.15	1196.88	2.74	23.76
2.	SAGILITY	44.57	21.01	20864.68	0.34	216.81	45.94	1963.48	27.59	13.82	22.32
3.	HORIZONIND	55.59	243.77	16026.06	0.00	-116.27	—	2005.46	—	3.32	80.26
4.	SYNGENE	384.20	70.18	15508.97	0.33	-9.00	-110.38	736.00	-15.84	9.48	12.34
5.	INDGN	577.00	34.68	13903.78	0.39	116.20	-0.17	1063.10	39.73	18.92	16.39
6.	IGIL	311.90	22.11	13479.06	1.60	165.74	30.98	370.78	23.22	77.00	60.35
7.	NESCO	1091.55	18.46	7691.06	0.64	99.96	3.97	211.80	9.55	19.23	48.33
8.	SPARC	196.95	4.03	6391.45	0.00	-20.78	59.94	39.92	314.11	163.94	-85.17
9.	LEAPIND	140.95	99.60	6209.36	0.00	247.33	—	2034.13	—	9.32	51.19
10.	SMARTWORKS	537.60	220.61	6149.13	0.00	13.15	413.27	546.25	44.05	61.12	63.33
11.	JUSTDIAL	667.45	15.64	5676.60	0.00	115.74	38.44	270.27	16.23	12.88	26.17
12.	LATENTVIEW	255.95	27.12	5300.30	0.00	47.10	-6.84	286.88	21.55	16.69	19.76

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	24	21	14	17	17	13	15	27	10	8	8	13	40
	126	113	116	122	110	116	89	80	62	74	65	80	84
Operating Profit	-102	-91	-103	-106	-93	-103	-74	-53	-52	-66	-57	-67	-44
OPM %	-426.64%	-431.87%	-740.40%	-639.07%	-555.38%	-800.23%	-494.23%	-195.59%	-540.25%	-836.13%	-670.30%	-506.21%	-111.05%
	10	8	6	4	2	0	0	0	9	0	-12	2	24
Interest	0	0	0	1	1	1	3	5	6	8	9	12	8
Depreciation	3	3	3	3	3	3	3	3	3	3	3	2	2
Profit before Tax	-95	-86	-100	-105	-96	-107	-79	-61	-52	-76	-80	1,761	-21
Tax %	-0.00%	-0.00%	-0.00%	-0.36%	-0.42%	-0.15%	-0.09%	1.48%	-0.12%	-0.08%	-0.09%	-0.02%	-0.53%
Net Profit	0	0	0	0	-96	-107	-80	-60	-52	-76	-80	1,761	-21
	-2.94	-2.66	-3.07	-3.26	-2.96	-3.31	-2.45	-1.84	-1.60	-2.34	-2.48	54.27	-0.64

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	239	76	72	1,879	69
	453	478	395	280	303
Operating Profit	-214	-402	-323	1,599	-234
OPM %	-89.65%	-532.26%	-450.27%	85.08%	-336.32%
	11	29	2	-1	13
Interest	8	2	9	34	36
Depreciation	12	13	12	10	10
Profit before Tax	-223	-387	-343	1,553	1,584
Tax %	-0.00%	-0.10%	0.08%	-0.01%	-0.01%
Net Profit	-223	-387	-343	1,553	1,584
EPS	-7.82	-11.93	-10.55	47.86	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 99%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: -6%
5 Years:: -8%
3 Years:: -6%
1 Year:: 36%

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 52%
Last Year:: 277%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	32	32	32	32
	480	93	-249	1,306
	130	165	329	622
Trade Payables	148	142	114	97
	39	81	107	111
Total Liabilities	830	514	333	2,169
	106	108	99	85
Capital Work in Progress	2	1	1	0
	291	2	0	0
	0	16	16	8
Cash & Bank	112	155	2	1
	320	232	216	2,073
Total Assets	830	514	333	2,169

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-74	-429	-360	-239
Cash from Investing	-548	392	158	-23
Cash from Financing	617	42	199	261
	-1	5	-3	-1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	65.67	65.67	65.67	65.67	65.67	65.67	65.67	65.67	65.67
	2.64	2.15	2.23	1.45	1.48	1.76	2.04	2.04	3.90
	0.17	0.21	0.63	1.12	0.96	1.03	0.78	0.87	0.08
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	31.52	31.96	31.48	31.76	31.89	31.53	31.52	31.42	30.34

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-13

General Updates

2026-08-13 - Sun Pharma Advanced Research Company Limited has informed the Exchange about Filing of Application for Reclassification with Stock Exchanges

2026-08-11

Copy of Newspaper Publication

2026-08-11 - Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-10

Shareholders meeting

2026-08-10 - Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 10, 2026

2026-08-10

Monitoring Agency Report

2026-08-10 - Sun Pharma Advanced Research Company Limited has informed the Exchange about Monitoring Agency Report for the quarter ended June 30, 2026.

2026-08-10

Outcome of Board Meeting

2026-08-10 - Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Outcome of Board Meeting held on August 10, 2026.

2026-08-10

Outcome of Board Meeting

2026-08-10 - Sun Pharma Advanced Research Company Limited has submitted to the Exchange, the Unaudited Financial Results for the quarter ended June 30, 2026.

2026-07-27

Updates

2026-07-27 - Sun Pharma Advanced Research Company Limited has informed the Exchange about Receipt of requests for reclassification of shareholder category

2026-07-17

Copy of Newspaper Publication

2026-07-17 - Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-16

Shareholders meeting

2026-07-16 - Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 10, 2026 along with the Annual Report for FY 2025-26

News

Recent coverage and analyst commentary for SPARC

Loading news…

🤖

AI Stock Analyst

Sun Pharma Advanced Research Company Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

PFOCUS

312.75

210.73

24356.15

0.00

-457.78

-514.43

12668.15

1196.88

2.74

23.76

SAGILITY

44.57

21.01

20864.68

0.34

216.81

45.94

1963.48

27.59

13.82

22.32

HORIZONIND

55.59

243.77

16026.06

0.00

-116.27

—

2005.46

—

3.32

80.26

SYNGENE

384.20

70.18

15508.97

0.33

-9.00

-110.38

736.00

-15.84

9.48

12.34

INDGN

577.00

34.68

13903.78

0.39

116.20

-0.17

1063.10

39.73

18.92

16.39

IGIL

311.90

22.11

13479.06

1.60

165.74

30.98

370.78

23.22

77.00

60.35

NESCO

1091.55

18.46

7691.06

0.64

99.96

3.97

211.80

9.55

19.23

48.33

SPARC

196.95

4.03

6391.45

0.00

-20.78

59.94

39.92

314.11

163.94

-85.17

LEAPIND

140.95

99.60

6209.36

0.00

247.33

—

2034.13

—

9.32

51.19

SMARTWORKS

537.60

220.61

6149.13

0.00

13.15

413.27

546.25

44.05

61.12

63.33

JUSTDIAL

667.45

15.64

5676.60

0.00

115.74

38.44

270.27

16.23

12.88

26.17

LATENTVIEW

255.95

27.12

5300.30

0.00

47.10

-6.84

286.88

21.55

16.69

19.76

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

126

113

116

122

110

116

Operating Profit

-102

-91

-103

-106

-93

-103

-74

-53

-52

-66

-57

-67

-44

OPM %

-426.64%

-431.87%

-740.40%

-639.07%

-555.38%

-800.23%

-494.23%

-195.59%

-540.25%

-836.13%

-670.30%

-506.21%

-111.05%

-12

Interest

Depreciation

Profit before Tax

-95

-86

-100

-105

-96

-107

-79

-61

-52

-76

-80

1,761

-21

Tax %

-0.00%

-0.36%

-0.42%

-0.15%

-0.09%

1.48%

-0.12%

-0.08%

-0.09%

-0.02%

-0.53%

Net Profit

-96

-107

-80

-60

-52

-76

-80

1,761

-21

-2.94

-2.66

-3.07

-3.26

-2.96

-3.31

-2.45

-1.84

-1.60

-2.34

-2.48

54.27

-0.64

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

239

1,879

453

478

395

280

303

Operating Profit

-214

-402

-323

1,599

-234

OPM %

-89.65%

-532.26%

-450.27%

85.08%

-336.32%

-1

Interest

Depreciation

Profit before Tax

-223

-387

-343

1,553

1,584

Tax %

-0.00%

-0.10%

0.08%

-0.01%

Net Profit

-223

-387

-343

1,553

1,584

EPS

-7.82

-11.93

-10.55

47.86

—

Dividend Payout %

0.00%

—

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

480

-249

1,306

130

165

329

622

Trade Payables

148

142

114

107

111

Total Liabilities

830

514

333

2,169

106

108

Capital Work in Progress

291

Cash & Bank

112

155

320

232

216

2,073

Total Assets

830

514

333

2,169

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-74

-429

-360

-239

Cash from Investing

-548

392

158

-23

Cash from Financing

617

199

261

-1

-3

-1

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

65.67

2.64

2.15

2.23

1.45

1.48

1.76

2.04

3.90

0.17

0.21

0.63

1.12

0.96

1.03

0.78

0.87

0.08

Government

0.00

31.52

31.96

31.48

31.76

31.89

31.53

31.52

31.42

30.34

Sun Pharma Advanced Research Company Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Sun Pharma Advanced Research Company Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI